IBRX STOCK ANALYSIS

Immunitybio Inc — price, returns and risk statistics

IBRXImmunitybio Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Last Close

9.44 $

Jul 2, 26

Market Cap

9.7 B $

Q1 2026 (TTM)

52-Week Range

Total Return

%+257.6

Trailing 1-year performance

Volatility

%104.9

Price fluctuation measure

Sharpe Ratio

1.33

Risk/Return ratio

Sortino Ratio

1.78

Downside risk/return

Distance to Peak

%-18.3

Difference from 52-week peak

Maximum Drawdown

-%42.3

Deepest 1-year decline

Seasonality Chart

Year 2023

Year 2024

Year 2025

Current Period 2026

3/3 positive months

Periodic Returns

+30.6%

+29.3%

+376.8%

YTD

+376.8%

+257.6%

+244.5%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly Avg Positive/Negative Close

Positive Count

Negative Count

Average Positive %

Average Negative %

Frequently Asked Questions

What is the current Immunitybio Inc (IBRX) stock price?

IBRX last closed at 9.44 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the market capitalization of Immunitybio Inc?

Immunitybio Inc (IBRX) has a market capitalization of approximately 9.7 B $ as of the latest reported period.

Who are the main competitors of IBRX?

Key peers of Immunitybio Inc include CSL Ltd, TELIX Pharmaceuticals Ltd, Mesoblast Ltd. A detailed metric comparison is available on the Peers tab.

Go deeper on IBRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.